• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

壳聚糖包覆的纳米结构脂质载体用于经皮递送四氢姜黄素治疗乳腺癌。

Chitosan-coated nanostructured lipid carriers for transdermal delivery of tetrahydrocurcumin for breast cancer therapy.

机构信息

Center of Excellence in Natural Products for Ageing and Chronic Diseases, Chulalongkorn University, Bangkok 10330, Thailand; Pharmaceutical Sciences and Technology Program, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.

Center of Excellence in Natural Products for Ageing and Chronic Diseases, Chulalongkorn University, Bangkok 10330, Thailand; Pharmaceutical Sciences and Technology Program, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.

出版信息

Carbohydr Polym. 2022 Jul 15;288:119401. doi: 10.1016/j.carbpol.2022.119401. Epub 2022 Mar 24.

DOI:10.1016/j.carbpol.2022.119401
PMID:35450653
Abstract

Chitosan (Ch)-coated nanostructured lipid carriers (NLCs) have great potential for transdermal delivery with high localization of chemotherapeutics in breast cancer. This study used tetrahydrocurcumin (THC), a primary metabolite of curcumin with enhanced antioxidant and anticancer properties, as a model compound to prepare NLCs. Response surface methodology was employed to optimize THC-loaded Ch-coated NLCs (THC-Ch-NLCs) fabricated by high-shear homogenization. The optimized THC-Ch-NLCs had particle size of 244 ± 18 nm, zeta potential of -17.5 ± 0.5 mV, entrapment efficiency of 76.6 ± 0.2% and drug loading of 0.28 ± 0.01%. In vitro release study of THC-Ch-NLCs showed sustained release following the Korsmeyer-Peppas model with Fickian and non-Fickian diffusion at pH 7.4 and 5.5, respectively. THC-Ch-NLCs demonstrated significantly enhanced in vitro skin permeation, cell uptake, and remarkable cytotoxicity toward MD-MBA-231 breast cancer cells compared to the unencapsulated THC, suggesting Ch-NLCs as potential transdermal nanocarriers of THC for triple-negative breast cancer treatment.

摘要

壳聚糖(Ch)涂层的纳米结构化脂质载体(NLCs)具有将化学疗法药物高度定位在乳腺癌中的经皮递药的巨大潜力。本研究使用四氢姜黄素(THC)作为模型化合物来制备 NLCs,THC 是姜黄素的主要代谢物,具有增强的抗氧化和抗癌特性。采用响应面法优化了通过高剪切匀化制备的负载姜黄素的壳聚糖(Ch)涂层的纳米结构化脂质载体(THC-Ch-NLCs)。优化的 THC-Ch-NLCs 的粒径为 244 ± 18nm,Zeta 电位为-17.5 ± 0.5mV,包封效率为 76.6 ± 0.2%,载药量为 0.28 ± 0.01%。THC-Ch-NLCs 的体外释放研究表明,在 pH 7.4 和 5.5 下,分别遵循 Korsmeyer-Peppas 模型,呈现出溶出的持续释放,具有 Fickian 和非 Fickian 扩散。与未包封的 THC 相比,THC-Ch-NLCs 表现出显著增强的体外皮肤渗透、细胞摄取以及对 MD-MBA-231 乳腺癌细胞的显著细胞毒性,表明 Ch-NLCs 是治疗三阴性乳腺癌的潜在经皮纳米载体。

相似文献

1
Chitosan-coated nanostructured lipid carriers for transdermal delivery of tetrahydrocurcumin for breast cancer therapy.壳聚糖包覆的纳米结构脂质载体用于经皮递送四氢姜黄素治疗乳腺癌。
Carbohydr Polym. 2022 Jul 15;288:119401. doi: 10.1016/j.carbpol.2022.119401. Epub 2022 Mar 24.
2
Curcumin-loaded nanostructured lipid carriers prepared using Peceol™ and olive oil in photodynamic therapy: development and application in breast cancer cell line.载姜黄素的纳米结构脂质载体,采用 PeceolTM 和橄榄油用于光动力疗法:在乳腺癌细胞系中的制备和应用。
Int J Nanomedicine. 2019 Jul 11;14:5073-5085. doi: 10.2147/IJN.S210484. eCollection 2019.
3
Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).基于质量源于设计(QbD)理念开发的醋氯芬酸纳米结构脂质载体(NLCs):改善炎症性疾病的皮肤动力学特征。
Int J Pharm. 2017 Jan 30;517(1-2):413-431. doi: 10.1016/j.ijpharm.2016.12.010. Epub 2016 Dec 9.
4
Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.负载度他雄胺的硬脂酸 - 壳聚糖低聚物包衣纳米结构脂质载体的制备及其表征,用于局部给药。
Eur J Pharm Biopharm. 2017 Aug;117:372-384. doi: 10.1016/j.ejpb.2017.04.012. Epub 2017 Apr 12.
5
Formulation of intranasal surface engineered nanostructured lipid carriers of rotigotine: Full factorial design optimization, in vitro characterization, and pharmacokinetic evaluation.罗替戈汀鼻腔表面工程化纳米结构脂质载体的制剂研究:全因子设计优化、体外特性评价及药代动力学评估。
Int J Pharm. 2022 Nov 5;627:122232. doi: 10.1016/j.ijpharm.2022.122232. Epub 2022 Sep 23.
6
Preparation of Chitosan-Coated Nanostructured Lipid Carriers (CH-NLCs) to Control Iron Delivery and Their Potential Application to Food Beverage System.壳聚糖包被的纳米结构脂质载体(CH-NLCs)的制备以控制铁的递送及其在食品饮料体系中的潜在应用
J Food Sci. 2017 Apr;82(4):904-912. doi: 10.1111/1750-3841.13655. Epub 2017 Feb 27.
7
Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.姜黄素引导的纳米疗法:一种用于乳腺癌治疗中靶向药物递送的脂质基纳米药物。
Drug Deliv. 2016 May;23(4):1420-5. doi: 10.3109/10717544.2015.1066902. Epub 2015 Jul 23.
8
Synthesis of Nanostructured Lipid Carriers Loaded Chitosan/ Carbopol Hybrid Nanocomposite Gel for Oral Delivery of Artemether and Curcumin.用于蒿甲醚和姜黄素口服递送的负载壳聚糖/卡波姆杂化纳米复合材料凝胶的纳米结构脂质载体的合成
Pharm Nanotechnol. 2020;8(5):418-432. doi: 10.2174/2211738508666200907110444.
9
Novel Strategies against Cancer: Dexibuprofen-Loaded Nanostructured Lipid Carriers.新型抗癌策略:负载双氯芬酸的纳米结构脂质载体。
Int J Mol Sci. 2022 Sep 25;23(19):11310. doi: 10.3390/ijms231911310.
10
Formulation of Chitosan-Coated Piperine NLCs: Optimization, In Vitro Characterization, and In Vivo Preclinical Assessment.壳聚糖包覆胡椒碱 NLC 的配方优化、体外特性研究及体内临床前评估。
AAPS PharmSciTech. 2021 Aug 31;22(7):231. doi: 10.1208/s12249-021-02098-4.

引用本文的文献

1
Plant metabolites and functional foods in metastatic breast cancer: a supportive strategy for management.植物代谢产物与功能性食品在转移性乳腺癌中的作用:一种辅助治疗策略
Front Pharmacol. 2025 Jul 23;16:1631232. doi: 10.3389/fphar.2025.1631232. eCollection 2025.
2
Transdermal Drug Delivery Systems: Methods for Enhancing Skin Permeability and Their Evaluation.经皮给药系统:增强皮肤渗透性的方法及其评价
Pharmaceutics. 2025 Jul 20;17(7):936. doi: 10.3390/pharmaceutics17070936.
3
How Effective are Key Phytocompound Carrying Polysaccharide Nanocarriers as Anti-Breast Cancer Therapy? A Comprehensive Review of the Literature.
携带关键植物化合物的多糖纳米载体作为抗乳腺癌疗法的效果如何?文献综述
Int J Nanomedicine. 2025 Jun 27;20:8393-8413. doi: 10.2147/IJN.S520580. eCollection 2025.
4
Role of Curcumin in Chronic Liver Diseases: A Comprehensive Review.姜黄素在慢性肝病中的作用:综述
Drug Des Devel Ther. 2025 Apr 28;19:3395-3406. doi: 10.2147/DDDT.S518547. eCollection 2025.
5
Co-encapsulated Ce6 + CpG and biopeptide-modified liposomes for enhanced transdermal photo-immunotherapy of superficial tumors.共包封Ce6+ CpG和生物肽修饰脂质体用于增强浅表肿瘤的经皮光免疫治疗
Mater Today Bio. 2025 Mar 13;32:101669. doi: 10.1016/j.mtbio.2025.101669. eCollection 2025 Jun.
6
Emerging Nanoparticle-Based Diagnostics and Therapeutics for Cancer: Innovations and Challenges.新兴的基于纳米颗粒的癌症诊断与治疗:创新与挑战
Pharmaceutics. 2025 Jan 7;17(1):70. doi: 10.3390/pharmaceutics17010070.
7
Curcumin Administration Routes in Breast Cancer Treatment.姜黄素在乳腺癌治疗中的给药途径。
Int J Mol Sci. 2024 Oct 26;25(21):11492. doi: 10.3390/ijms252111492.
8
The anticancer potential of tetrahydrocurcumin-phytosomes against oral carcinoma progression.四氢姜黄素-植物甾醇体对口腔癌进展的抗癌潜力。
BMC Oral Health. 2024 Sep 26;24(1):1126. doi: 10.1186/s12903-024-04856-9.
9
Research Advances of Lipid Nanoparticles in the Treatment of Colorectal Cancer.脂质纳米粒在结直肠癌治疗中的研究进展。
Int J Nanomedicine. 2024 Jul 3;19:6693-6715. doi: 10.2147/IJN.S466490. eCollection 2024.
10
Application of nanoparticles in breast cancer treatment: a systematic review.纳米粒子在乳腺癌治疗中的应用:系统评价。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep;397(9):6459-6505. doi: 10.1007/s00210-024-03082-y. Epub 2024 May 3.